Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income $ 3,316,457 $ 355,624
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 199,481 200,865
Non-cash interest expense, net of amortization of premium 30,786 29,211
Provision for doubtful accounts 24,953 26,209
Amortization of deferred income related to equity method investment (2,082) (2,082)
Loss on extinguishment of debt and credit facilities, net 132,726 7,206
Gain on merger of unconsolidated entities 0 (84,855)
Loss on unconsolidated entity investments, net 4,014 10,259
Loss on disposal of assets 567 269
Share-based payment expense 46,361 37,574
Deferred income taxes (3,017,021) 7,214
Other non-cash purchase price adjustments (220,336) (203,630)
Distribution from investment in unconsolidated entity 0 4,849
Changes in operating assets and liabilities:    
Accounts receivable (26,211) (1,456)
Receivables from distributors (2,956) (12,358)
Inventory 888 (14,278)
Related party assets 6,905 30,300
Prepaid expenses and other current assets (26,367) (11,028)
Other long-term assets 24,454 23,969
Accounts payable and accrued expenses (27,384) (100,502)
Accrued interest (5,940) 6,472
Deferred revenue 52,777 19,653
Related party liabilities (1,314) 696
Other long-term liabilities 2,774 (1,547)
Net cash provided by operating activities 513,532 328,634
Cash flows from investing activities:    
Additions to property and equipment (73,546) (115,065)
Release of restricted investments 0 250
Return of capital from investment in unconsolidated entity 0 10,117
Net cash used in investing activities (73,546) (104,698)
Cash flows from financing activities:    
Proceeds from exercise of stock options 89,250 9,045
Long-term borrowings, net of costs 393,687 0
Payment of premiums on redemption of debt (100,615) (5,020)
Repayment of long-term borrowings (914,028) (210,060)
Repayment of related party long-term borrowings (126,000) 0
Net cash used in financing activities (657,706) (206,035)
Net (decrease) increase in cash and cash equivalents (217,720) 17,901
Cash and cash equivalents at beginning of period 773,990 586,691
Cash and cash equivalents at end of period 556,270 604,592
Cash paid during the period for:    
Interest, net of amounts capitalized 188,997 235,096
Non-cash investing and financing activities:    
Conversion of Series B preferred stock to common stock 1,294 0
Capital lease obligations incurred to acquire assets 12,781 0
Common stock issuance upon exercise of warrants 0 7
Goodwill reduced for the exercise and vesting of certain stock awards $ 19,183 $ 0